bioMérieux expands point-of-care diagnostics with SpinChip acquisition
This innovative technology aims to improve acute care outcomes, particularly for myocardial infarction diagnosis.
This innovative technology aims to improve acute care outcomes, particularly for myocardial infarction diagnosis.
Tropical Fever Panel a syndromic PCR test, targets the causes of tropical fever infections
For use on all VIDAS immunoanalyzers, VIDAS VITAMIN B12 TOTAL is an automated quantitative blood test that measures total vitamin B12 concentration
Understand the importance of fostering cross-department collaboration for an optimal antimicrobial stewardship program
bioMérieux, announces that its VITEK REVEAL AST System, reporting results directly from positive blood cultures, has received US Food and Drug Administration (FDA) 510(k) clearance
The respiratory/sore throat (R/ST) panel receives Dual 510(k) clearance and CLIA-waiver approval
Rapid and accurate multiplex PCR-based test brings critical results to the patient in just 15 minutes
The latest addition to this innovative range combines advanced technology with the recognized values of the VIDAS solution
Based on single-sample testing the VIDAS Anti-CHIKUNGUNYA IgM and IgG are easy to use and accessible to all laboratories
The BIOFIRE solution is a U.S. FDA-cleared and CE-marked closed multiplex PCR and fully automated system that integrates sample preparation, amplification, and detection
New mobile application will help clinicians choose the right biomarker tests to order for a particular patient and facilitate the interpretation of results
bioMérieux conducts in-depth analyses of its molecular tests on emerging variants of concern
EPISEQ SARS-COV-2 will support microbiology labs in identification and reporting from raw sequencing data related to SARS-CoV-2 variants
Easy-to-use molecular biology test delivers results in less than one hour
The new system demonstrates bioMérieux’s commitment to automated blood culture - a foundational step to infectious disease diagnosis